MORISE Masahiro 森瀬昌宏

… Alternative Names

森瀬昌宏モリセマサヒロ

MASAHIRO MORISE 森瀬昌宏

Less

Researcher Number	00612756
Other IDs
Affiliation (Current)	2025: 名古屋大学, 医学系研究科, 講師
Affiliation (based on the past Project Information) *help	2020 – 2023: 名古屋大学, 医学系研究科, 講師 2019 – 2021: 名古屋大学, 医学部附属病院, 病院講師 2015 – 2017: 名古屋大学, 医学部附属病院, 病院助教 2014: 名古屋大学, 医学部附属病院, 助教 2013: 独立行政法人国立がん研究センター, 東病院呼吸器内科, がん専門修練医
Review Section/Research Field	Principal Investigator Basic Section 52010:General internal medicine-related / General internal medicine(including psychosomatic medicine) Except Principal Investigator Basic Section 53030:Respiratory medicine-related / General internal medicine(including psychosomatic medicine)
Keywords	Principal Investigator VEGF-A / 悪性胸膜中皮腫 / 機械学習 / 胸腺腫瘍 / 肺癌 / 血管新生阻害治療 / 血管新生阻害剤 / アウトカム予測 / 発熱性好中球減少症 / 脆弱性 / 消化器毒性 / 化学療法 / 高齢者 … More Except Principal Investigator … More PDXマウス / 細胞増殖 / 新規治療標的 / 新規治療戦略 / 細胞周期停止 / 腫瘍増殖因子 / 新規個別化治療 / ドラッグリポジショニング / 予後因子 / 細胞周期制御因子 / オキシトシン受容体阻害剤 / オキシトシン / オキシトシン受容体 / 悪性中皮腫 / アウトカム予測 / 機能評価 / 化学療法 / がん / 高齢者 Less

肺神経内分泌腫瘍に対する腫瘍血管新生を標的とした治療の低侵襲効果予測法の確立Principal Investigator
- Principal Investigator
  
  森瀬昌宏
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Nagoya University
Oxytocin receptor is a promising therapeutic target of malignant mesothelioma
- Principal Investigator
  
  TANAKA ICHIDAI
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53030:Respiratory medicine-related
- Research Institution
  Nagoya University
呼吸器悪性腫瘍における血管新生阻害治療の低侵襲な効果予測法を確立をめざす研究Principal Investigator
- Principal Investigator
  
  森瀬昌宏
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Nagoya University
Fundamental research for treatment optimization in elderly patients with mesotheliomaPrincipal Investigator
- Principal Investigator
  
  MASAHIRO MORISE
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General internal medicine(including psychosomatic medicine)
- Research Institution
  Nagoya University
An observational study for evaluating predictability of the Vulnerable Elders Survey (VES) -13 for cognitive impairment in elderly patients with advanced cancer
- Principal Investigator
  
  Ando Masahiko
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General internal medicine(including psychosomatic medicine)
- Research Institution
  Nagoya University

All 2022 2021 2020 2019 2017 2016 2015 Other

All Journal Article Presentation

[Journal Article] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis2022
- Author(s)
  Gen Soei、Tanaka Ichidai、Morise Masahiro、Koyama Junji、Kodama Yuta、Matsui Akira、Miyazawa Ayako、Hase Tetsunari、Hibino Yoshitaka、Yokoyama Toshihiko、Kimura Tomoki、Yoshida Norio、Sato Mitsuo、Hashimoto Naozumi
- Journal Title
  
  BMC Cancer
  
  Volume: 22 Issue: 1 Pages: 654-654
- DOI
  10.1186/s12885-022-09741-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910
[Journal Article] Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade2022
- Author(s)
  Kobayashi Tomoko、Iwama Shintaro、Morise Masahiro、Hashimoto Naozumi、Arima Hiroshi 他
- Journal Title
  
  The Journal of Clinical Endocrinology & Metabolism
  
  Volume: 107 Issue: 10 Pages: e4115-e4123
- DOI
  10.1210/clinem/dgac467
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07910, KAKENHI-PROJECT-21K16352
[Journal Article] Resistance to mutant KRAS V12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line2022
- Author(s)
  Muraki N, Yamada M, Doki H, Nakai R, Komeda K, Goto D, Kawabe N, Matsuoka K, Matsushima M, Kawabe T, Tanaka I, Morise M, Shay JW, Minna JD, Sato M.
- Journal Title
  
  Exp Cell Res .
  
  Volume: 414 Issue: 1 Pages: 113053-113053
- DOI
  10.1016/j.yexcr.2022.113053
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K22617, KAKENHI-PROJECT-21H02924, KAKENHI-PROJECT-20K07824, KAKENHI-PROJECT-20K11529, KAKENHI-PROJECT-19K07910, KAKENHI-PROJECT-22K19522
[Journal Article] Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR2022
- Author(s)
  Matsuzawa Reiko、Morise Masahiro、Kinoshita Fumie、Tanaka Ichidai、Koyama Junji、Kimura Tomoki、Kondoh Yasuhiro、Tanaka Taro、Shima Koichiro、Hase Tetsunari、Wakahara Keiko、Ishii Makoto、Hashimoto Naozumi
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: 未定 Issue: 7 Pages: 3885-3893
- DOI
  10.1007/s00432-022-04300-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910
[Journal Article] Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)2021
- Author(s)
  Takeuchi Shinji、Yanagitani Noriko、Seto Takashi、Hattori Yoshihiro、Ohashi Kadoaki、Morise Masahiro、Matsumoto Shingo、Yoh Kiyotaka、Goto Koichi、Nishio Makoto、Takahara Shizuko、Kawakami Takahiro、Imai Yasuhito、Yoshimura Kenichi、Tanimoto Azusa、Nishiyama Akihiro、Murayama Toshinori、Yano Seiji
- Journal Title
  
  Translational Lung Cancer Research
  
  Volume: 10 Issue: 1 Pages: 314-325
- DOI
  10.21037/tlcr-20-549
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08516, KAKENHI-PROJECT-19K08625, KAKENHI-PROJECT-19K07910
[Journal Article] A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer.2021
- Author(s)
  Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, Takeuchi S, Morise M, Hotta K, Sato M, Matsumoto S, Tanimoto A, Matsuzawa R, Kiura K, Takashima Y, Yano S, Koyama J, Fukushima T, Hamamoto J, Terai H, Ikemura S, Takemura R, Goto K, Soejima K.
- Journal Title
  
  Lung Cancer
  
  Volume: 162 Pages: 140-146
- DOI
  10.1016/j.lungcan.2021.10.006
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03671, KAKENHI-PROJECT-19K07910
[Journal Article] Oxytocin receptor is a promising therapeutic target of malignant mesothelioma2021
- Author(s)
  Oxytocin receptor is a promising therapeutic target of malignant mesothelioma. Kodama Y, Tanaka I, Sato T, Hori K, Gen S, Morise M, Matsubara D, Sato M, Sekido Y, Hashimoto N.
- Journal Title
  
  Cancer science
  
  Volume: 112 Issue: 9 Pages: 3520-3532
- DOI
  10.1111/cas.15025
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K22617, KAKENHI-PROJECT-19H03527, KAKENHI-PROJECT-20K21599, KAKENHI-PROJECT-20H03689
[Journal Article] Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations2021
- Author(s)
  Tanaka Ichidai、Morise Masahiro
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 1 Pages: 245-245
- DOI
  10.3390/ijms23010245
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07910
[Journal Article] Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer2020
- Author(s)
  Matsui Akira、Morise Masahiro、Tanaka Ichidai、Ozone Sachiko、Matsuzawa Reiko、Koyama Junji、Hase Tetsunari、Hashimoto Naozumi、Sato Mitsuo、Hasegawa Yoshinori
- Journal Title
  
  Cancer Investigation
  
  Volume: 38 Issue: 7 Pages: 424-430
- DOI
  10.1080/07357907.2020.1793350
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910
[Journal Article] Clinical burden of immune checkpoint inhibitor-induced pneumonitis2020
- Author(s)
  Sakamoto Koji、Fukihara Jun、Morise Masahiro、Hashimoto Naozumi
- Journal Title
  
  Respiratory Investigation
  
  Volume: 58 Issue: 5 Pages: 305-319
- DOI
  10.1016/j.resinv.2020.05.008
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910, KAKENHI-PROJECT-20K21599, KAKENHI-PROJECT-18K15948
[Journal Article] Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.2020
- Author(s)
  Tanaka I, Morise M, Miyazawa A, Kodama Y, Tamiya Y, Gen S, Matsui A, Hase T, Hashimoto N, Sato M, Hasegawa Y.
- Journal Title
  
  Clinical lung cancer
  
  Volume: -
- NAID
  120006884970
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910
[Journal Article] UHRF1, a Regulator of Methylation, as a Diagnostic and Prognostic Marker for Lung Cancer2020
- Author(s)
  Goto Daiki、Komeda Kazuki、Uwatoko Natsuki、Nakashima Moeka、Koike Mayu、Kawai Kaho、Kodama Yuta、Miyazawa Ayako、Tanaka Ichidai、Hase Tetsunari、Morise Masahiro、Hasegawa Yoshinori、Kawabe Tsutomu、Sato Mitsuo
- Journal Title
  
  Cancer Investigation
  
  Volume: 38 Issue: 4 Pages: 240-249
- DOI
  10.1080/07357907.2020.1747483
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07910, KAKENHI-PROJECT-18H02819
[Journal Article] Reply to “Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non?Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors”2019
- Author(s)
  Fukihara Jun、Sakamoto Koji、Koyama Junji、Ito Takayasu、Iwano Shingo、Morise Masahiro、Ogawa Masahiro、Kondoh Yasuhiro、Kimura Tomoki、Hashimoto Naozumi、Hasegawa Yoshinori
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 19 Issue: 3 Pages: 30330-4
- DOI
  10.1016/j.cllc.2019.11.013
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K15948, KAKENHI-PROJECT-19K07910
[Journal Article] Factors Affecting the Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in Peripheral Lung Cancer2016
- Author(s)
  Shotaro Okachi, Naoyuki Imai, Kazuyoshi Imaizumi, Shingo Iwano, Masahiko Ando, Tetsunari Hase, Hiromichi Aso, Masahiro Morise, Keiko Wakahara, Satoru Ito, Naozumi Hashimoto, Mitsuo Sato, Masashi Kondo, and Yoshinori Hasegawa
- Journal Title
  
  Intern. Med.
  
  Volume: 55 Issue: 13 Pages: 1705-1712
- DOI
  10.2169/internalmedicine.55.6341
- NAID
  130005161019
- ISSN
  0918-2918, 1349-7235
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460896, KAKENHI-PROJECT-15K19282
[Journal Article] Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?2016
- Author(s)
  1.Toshio Kato, Masahiro Morise, Masahiko Ando, Eiji Kojima, Tomohiko Ogasawara, Ryujiro Suzuki, Joe Shindoh, Masami Matsumoto, Yasuteru Sugino, Masahiro Ogawa, Yasuhiro Nozaki, Tetsunari Hase, Masashi Kondo, Hiroshi Saito, and Yoshinori Hasegawa
- Journal Title
  
  J Cancer Res Clin Oncol
  
  Volume: 142 Issue: 7 Pages: 1629-1640
- DOI
  10.1007/s00432-016-2170-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25460896
[Presentation] 悪性中皮腫におけるオキシトシン受容体(OXTR)を標的とした新規治療法の開発2021
- Author(s)
  小玉勇太, 田中一大, 佐藤龍洋, 玄崇永, 堀和美, 森瀬昌宏, 佐藤光夫, 関戸好孝
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-20H03689
[Presentation] 小細胞肺癌をはじめとする肺神経内分泌腫瘍に対する治療～肺癌診療ガイドラインにおける治療推奨を踏まえて2020
- Author(s)
  森瀬昌宏
- Organizer
  第61回日本肺癌学会総会ワークショップ
- Invited
- Data Source
  KAKENHI-PROJECT-19K07910
[Presentation] Does the histological differentiation of NSCLC affect the efficacy of immune checkpoint inhibitors?2020
- Author(s)
  Masahiro Morise
- Organizer
  第60回日本呼吸器学会総会 International Session
- Data Source
  KAKENHI-PROJECT-19K07910
[Presentation] 非小細胞肺癌における免疫チェックポイント阻害剤と細胞障害性抗癌薬との併用2020
- Author(s)
  森瀬昌宏
- Organizer
  第60回日本呼吸器学会総会シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-19K07910
[Presentation] 肺癌に対する免疫療法の近未来的展望放射線治療との併用2019
- Author(s)
  森瀬昌宏
- Organizer
  第59回日本呼吸器学会学術講演会
- Invited
- Data Source
  KAKENHI-PROJECT-19K07910
[Presentation] Serum CRP decrease has predictive value for long-term disease control by PD-1/ PD-L1 inhibitors in patients with NSCLC2019
- Author(s)
  Reiko Matsuzawa, Masahiro Morise, Ichidai Tanaka, Tomoki Kimura, Yasuhiro Kondoh, Tetsunari Hase, Koji Sakamoto, Naozumi Hashimoto, Yoshinori Hasegawa
- Organizer
  Japanese Society of Medical Oncology Annual meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K07910
[Presentation] 非扁平上皮非小細胞肺癌に対するカルボプラチン併用療法においてペメトレキセドは他の第三世代抗癌剤に対して有用か2017
- Author(s)
  安井　裕智、森瀬　昌宏、長谷　哲成、佐藤　光夫、近藤　征史、長谷川　好規
- Organizer
  第58回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] The indication ofprimary prevention forfebrile neutropenia (FN) in elderlyNSCLC patientstreated with docetaxel2016
- Author(s)
  Masahiro Morise, Masashi Kondo, Yoshinori Hasegawa
- Organizer
  14th Japanese Society of Medical Oncology Annual meeting, International symposium
- Place of Presentation
  兵庫県神戸市 (神戸国際会議場)
- Year and Date
  2016-07-28
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] 非小細胞肺癌（NSCLC）に対するドセタキセル（DTX）療法時のFebrileNeutropenia（FN）一次予防に関する検討2016
- Author(s)
  森瀬昌宏、長谷哲成、佐藤光夫、近藤征史、長谷川好規
- Organizer
  第57回日本肺癌学会学術集会
- Place of Presentation
  福岡県福岡市（福岡国際会議場）
- Year and Date
  2016-12-19
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] カルボプラチン併用療法に対する予防制吐療法のデキサメサゾン投与期間に関する検討2015
- Author(s)
  市川和哉,森瀬昌宏,宮崎雅之,杉本智哉,長谷哲成,佐藤光夫,近藤征史,長谷川好規,山田清文
- Organizer
  第56回日本肺癌学会学術集会
- Place of Presentation
  神奈川県横浜市（横浜国際平和会議場）
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] The Efficacy and Safety of Re-Challenge Platinum plus Pemetrexed Combination Therapy for Recurrent Malignant Pleural Mesothelioma2015
- Author(s)
  Mariko Morishita, Masahiro Morise, Tetsunari Hase, Mitsuo Sato, Masashi Kondoh, Yoshinori Hasegawa
- Organizer
  16th World Conference on Lung Cancer
- Place of Presentation
  Denver, USA
- Year and Date
  2015-09-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] 再発悪性胸膜中皮腫に対するプラチナ製剤＋ペメトレキセドre-challenge療法の有用性と安全性の検討2015
- Author(s)
  森瀬昌宏,森下真梨子,長谷哲成,佐藤光夫,近藤征史,長谷川好規
- Organizer
  第56回日本肺癌学会学術集会
- Place of Presentation
  神奈川県横浜市（横浜国際平和会議場）
- Year and Date
  2015-11-26
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] 肺がんシスプラチン併用抗がん剤における消化器毒性の比較2015
- Author(s)
  松永安未、宮崎雅之、市川和哉、森瀬昌宏、近藤征史、長谷川好規
- Organizer
  第23回クリニカルファーマシーシンポジウム
- Place of Presentation
  愛知県名古屋市（名古屋国際会議場）
- Year and Date
  2015-07-04
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] 肺癌カルボプラチン併用療法の予防制吐治療失敗の検討2015
- Author(s)
  市川和哉、森瀬昌宏、宮崎雅之、長谷哲成、近藤征史、長谷川好規、山田清文
- Organizer
  第13回日本臨床腫瘍学会学術集会
- Place of Presentation
  北海道札幌市（札幌市教育文化会館）
- Year and Date
  2015-07-16
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] 高齢者肺癌カルボプラチン併用療法における悪心・嘔吐のリスク因子の検討2015
- Author(s)
  市川和哉、森瀬昌宏、宮崎雅之、長谷哲成、近藤征史、長谷川好規、山田清文
- Organizer
  第25回日本医療薬学会年会
- Place of Presentation
  神奈川県横浜市（横浜国際平和会議場）
- Year and Date
  2015-11-21
- Data Source
  KAKENHI-PROJECT-15K08905
[Presentation] Can we predict serious adverse events (SAEs) and clarify unfit population for platinum-based chemotherapy in elderly patients (over 70 years of age) with advanced Non-small cell lung cancer (NSCLC)? 　(CJLSG 1203 trial)
- Author(s)
  Kato Toshio, Morise M, Ando M, Kojima E, Ogasawara T, Suzuki R, Shindoh J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Kondo M, Saito H, and Hasegawa Y
- Organizer
  European Society for Medical Oncology (ESMO) 2014
- Place of Presentation
  Madrid, Spain
- Year and Date
  2014-09-26 – 2014-09-30
- Data Source
  KAKENHI-PROJECT-25460896

1. Ando Masahiko (10322736)

# of Collaborated Projects: 3 results

# of Collaborated Products: 2 results
2. 菊地良介 (30721435)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. TANAKA ICHIDAI (40809810)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. 長谷哲成 (30621635)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. 近藤征史 (00378077)

# of Collaborated Projects: 1 results

# of Collaborated Products: 9 results
6. 木下文恵 (40775855)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 関戸好孝 (00311712)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
8. 佐藤光夫 (70467281)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
9. 松原大祐 (80415554)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. TAKEUCHI Shinji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. HAMAMOTO Junko

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 安田浩之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 副島研造

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 阪本考司

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

MORISE Masahiro 森瀬 昌宏

森瀬 昌宏 モリセ マサヒロ

MASAHIRO MORISE 森瀬 昌宏

Research Projects

Research Products

Co-Researchers

肺神経内分泌腫瘍に対する腫瘍血管新生を標的とした治療の低侵襲効果予測法の確立Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

呼吸器悪性腫瘍における血管新生阻害治療の低侵襲な効果予測法を確立をめざす研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Fundamental research for treatment optimization in elderly patients with mesotheliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

An observational study for evaluating predictability of the Vulnerable Elders Survey (VES) -13 for cognitive impairment in elderly patients with advanced cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Resistance to mutant KRAS V12-induced senescence in an hTERT/Cdk4-immortalized normal human bronchial epithelial cell line2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Oxytocin receptor is a promising therapeutic target of malignant mesothelioma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Primary Prophylaxis Indication for Docetaxel Induced Febrile Neutropenia in Elderly Patients with Non-Small Cell Lung Cancer2020

Author(s)

Journal Title

DOI

MORISE Masahiro 森瀬昌宏

森瀬昌宏モリセマサヒロ

MASAHIRO MORISE 森瀬昌宏

[Presentation] 肺癌に対する免疫療法の近未来的展望放射線治療との併用2019

[Presentation] 非小細胞肺癌（NSCLC）に対するドセタキセル（DTX）療法時のFebrileNeutropenia（FN）一次予防に関する検討2016